FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743014102> ?p ?o ?g. }

• W2743014102 endingPage "5088" @default.
• W2743014102 startingPage "5081" @default.
• W2743014102 abstract "Typhoid fever is estimated to cause between 11.9-26.9 million infections globally each year with 129,000-216,510 deaths. Access to improved water sources have reduced disease incidence in parts of the world but the use of efficacious vaccines is seen as an important public health tool for countries with a high disease burden. A new generation of Vi typhoid conjugate vaccines (TCVs), licensed for use in young children and expected to provide longer lasting protection than previous vaccines, are now available. The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has convened a working group to review the evidence on TCVs and produce an updated WHO position paper for all typhoid vaccines in 2018 that will inform Gavi, the Vaccine Alliance's future vaccine investment strategies for TCVs. The Typhoid Vaccine Acceleration Consortium (TyVAC) has been formed through a $36.9 million funding program from the Bill & Melinda Gates Foundation to accelerate the introduction of TCVs into Gavi-eligible countries. In October 2016, a meeting was held to initiate planning of TCV effectiveness studies that will provide the data required by policy makers and stakeholders to support decisions on TCV use in countries with a high typhoid burden. Discussion topics included (1) the latest evidence and data gaps in typhoid epidemiology; (2) WHO and Gavi methods and data requirements; (3) data on TCV efficacy; (4) cost effectiveness analysis for TCVs from mathematical models; (5) TCV delivery and effectiveness study design. Specifically, participants were asked to comment on study design in 3 sites for which population-based typhoid surveillance is underway. The conclusion of the meeting was that country-level decision making would best be informed by the respective selected sites in Africa and Asia vaccinating children aged from 9-months to 15-years-old, employing either an individual or cluster randomized design with design influenced by population characteristics, transmission dynamics, and statistical considerations." @default.
• W2743014102 created "2017-08-17" @default.
• W2743014102 creator A5016242677 @default.
• W2743014102 creator A5021173085 @default.
• W2743014102 creator A5023032597 @default.
• W2743014102 creator A5025149327 @default.
• W2743014102 creator A5028133425 @default.
• W2743014102 creator A5032122956 @default.
• W2743014102 creator A5033152609 @default.
• W2743014102 creator A5033292536 @default.
• W2743014102 creator A5033785570 @default.
• W2743014102 creator A5035517653 @default.
• W2743014102 creator A5036953632 @default.
• W2743014102 creator A5041043840 @default.
• W2743014102 creator A5041318439 @default.
• W2743014102 creator A5049145301 @default.
• W2743014102 creator A5049322283 @default.
• W2743014102 creator A5051550648 @default.
• W2743014102 creator A5059641375 @default.
• W2743014102 creator A5064496144 @default.
• W2743014102 creator A5065914659 @default.
• W2743014102 creator A5070628953 @default.
• W2743014102 creator A5078871250 @default.
• W2743014102 creator A5079913230 @default.
• W2743014102 creator A5080066240 @default.
• W2743014102 creator A5085793844 @default.
• W2743014102 creator A5090120637 @default.
• W2743014102 date "2017-09-01" @default.
• W2743014102 modified "2023-10-06" @default.
• W2743014102 title "The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26–27 October 2016, Oxford, UK" @default.
• W2743014102 cites W1779315825 @default.
• W2743014102 cites W1814034318 @default.
• W2743014102 cites W1968151569 @default.
• W2743014102 cites W1969104565 @default.
• W2743014102 cites W1988771307 @default.
• W2743014102 cites W1998738749 @default.
• W2743014102 cites W2000611496 @default.
• W2743014102 cites W2007401305 @default.
• W2743014102 cites W2021755623 @default.
• W2743014102 cites W2049532298 @default.
• W2743014102 cites W2054839242 @default.
• W2743014102 cites W2055690472 @default.
• W2743014102 cites W2060768148 @default.
• W2743014102 cites W2065122103 @default.
• W2743014102 cites W2090839261 @default.
• W2743014102 cites W2096608095 @default.
• W2743014102 cites W2101272705 @default.
• W2743014102 cites W2114213575 @default.
• W2743014102 cites W2115048812 @default.
• W2743014102 cites W2122598469 @default.
• W2743014102 cites W2128193010 @default.
• W2743014102 cites W2136544583 @default.
• W2743014102 cites W2139462981 @default.
• W2743014102 cites W2140447452 @default.
• W2743014102 cites W2143192949 @default.
• W2743014102 cites W2147278081 @default.
• W2743014102 cites W2149004255 @default.
• W2743014102 cites W2162157155 @default.
• W2743014102 cites W2171174324 @default.
• W2743014102 cites W2271281533 @default.
• W2743014102 cites W2290845654 @default.
• W2743014102 cites W2295783650 @default.
• W2743014102 cites W2295994332 @default.
• W2743014102 cites W2324367298 @default.
• W2743014102 cites W2331123322 @default.
• W2743014102 cites W2340127586 @default.
• W2743014102 cites W2340183786 @default.
• W2743014102 cites W2396494527 @default.
• W2743014102 cites W2405927069 @default.
• W2743014102 cites W2587454028 @default.
• W2743014102 cites W2593353559 @default.
• W2743014102 cites W2732320847 @default.
• W2743014102 cites W3125900386 @default.
• W2743014102 cites W4243637892 @default.
• W2743014102 cites W848939283 @default.
• W2743014102 doi "https://doi.org/10.1016/j.vaccine.2017.08.001" @default.
• W2743014102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28802757" @default.
• W2743014102 hasPublicationYear "2017" @default.
• W2743014102 type Work @default.
• W2743014102 sameAs 2743014102 @default.
• W2743014102 citedByCount "62" @default.
• W2743014102 countsByYear W27430141022018 @default.
• W2743014102 countsByYear W27430141022019 @default.
• W2743014102 countsByYear W27430141022020 @default.
• W2743014102 countsByYear W27430141022021 @default.
• W2743014102 countsByYear W27430141022022 @default.
• W2743014102 countsByYear W27430141022023 @default.
• W2743014102 crossrefType "journal-article" @default.
• W2743014102 hasAuthorship W2743014102A5016242677 @default.
• W2743014102 hasAuthorship W2743014102A5021173085 @default.
• W2743014102 hasAuthorship W2743014102A5023032597 @default.
• W2743014102 hasAuthorship W2743014102A5025149327 @default.
• W2743014102 hasAuthorship W2743014102A5028133425 @default.
• W2743014102 hasAuthorship W2743014102A5032122956 @default.
• W2743014102 hasAuthorship W2743014102A5033152609 @default.
• W2743014102 hasAuthorship W2743014102A5033292536 @default.
• W2743014102 hasAuthorship W2743014102A5033785570 @default.
• W2743014102 hasAuthorship W2743014102A5035517653 @default.

• next